期刊文献+

程序性坏死参与特发性肺纤维化的研究进展 被引量:5

Research progress of programmed necrosis in idiopathic pulmonary fibrosis
下载PDF
导出
摘要 特发性肺纤维化(IPF)是以肺泡上皮细胞损伤和成纤维细胞增生为特征的一类间质性肺疾病,患者的中位生存期仅为2~3年。近年来,程序性坏死作为可调控的坏死类型,被认为是介导炎症和纤维化的重要因素。最近研究发现了程序性坏死不仅参与了吸烟加速IPF的进展,还被证明了其与家族性IPF的发生有关,从而成为了研究IPF发生和发展的热点。文章主要就程序性坏死的发生机制及其参与IPF发生发展的研究进展进行综述。 Idiopathic pulmonary fibrosis(IPF)is a type of interstitial lung disease characterized by alveolar epithelial cell injury and fibroblast proliferation.The median survival of patients is only 2 to 3 years.In recent years,necroptosis,as controllable necrosis type,has been regarded as an important factor mediating inflammation and fibrosis.Recent studies have found that programmed necrosis not only involved in smoking to accelerate the progress of IPF,but also has been proved to be related to the occurrence of familial IPF,which has become a hot spot in the research on the occurrence and development of IPF.This article reviews the research advance in the mechanism of necroptosis and its involvement in the development of IPF.
作者 李思佳 李文新(综述) 宋新宇(审校) LI Si-jia;LI Wen-xin;SONG Xin-yu(The Second Department of Respiratory and Critical Care Unit,the First College of Clinical Science,China Three Gorges University/Yichang Central People's Hospital,Yichang 443003,Hubei,China)
出处 《医学研究生学报》 CAS 北大核心 2020年第11期1218-1222,共5页 Journal of Medical Postgraduates
基金 湖北省卫生计生委科研项目(WJ2019M062)。
关键词 特发性肺纤维化 程序性坏死 炎症 纤维化 idiopathic pulmonary fibrosis necroptosis inflammation fibrosis
  • 相关文献

参考文献3

二级参考文献43

  • 1Geng J, Huang X, Li Y, et al. Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis via multiple pathways[J]. Exp Biol Med (Maywood), 2016,241(2):157-165. 被引量:1
  • 2Bagnato G, Harari S. Cellular interactions in the pathogenesis of interstitial lung diseases[J]. Eur Respir Rev, 2015, 24(135): 102-114. 被引量:1
  • 3Wuyts WA, Agostini C, Antoniou KM, et al. The pathogenesis of pulmonary fibrosis: a moving target[J]. Eur Respir J, 2013, 41(5): 1207-1218. 被引量:1
  • 4Mccubbrey AL, Curtis JL. Efferocytosis and lung disease[J]. Chest, 2013, 143(6): 1750-1757. 被引量:1
  • 5Cai M, Bonella F, He X, et al. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases[J]. Respir Med, 2013, 107(9): 1444-1452. 被引量:1
  • 6Xiong S, Guo R, Yang Z, et al. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance[J]. Immunobiology, 2015, 220(11): 1284-1291. 被引量:1
  • 7Franois A, Gombault A, Villeret B, et al. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis[J]. J Autoimmun, 2015, 56: 1-11. 被引量:1
  • 8Yoshizaki A, Yanaba K, Ogawa A, et al. Immunization with DNA topoisomerase I and Freund′s complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling[J]. Arthritis Rheum, 2011, 63(11): 3575-3585. 被引量:1
  • 9Galati D, De Martino M, Trotta A, et al. Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients[J]. Cytokine, 2014, 66(2): 119-126. 被引量:1
  • 10Hams E, Armstrong ME, Barlow JL, et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis[J]. Proc Natl Acad Sci USA, 2014, 111(1): 367-372. 被引量:1

共引文献25

同被引文献56

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部